# Ex Vivo Human Thrombosis Chamber Study

> **NCT00935506** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 15 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00935506
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2011-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935506, "Ex Vivo Human Thrombosis Chamber Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00935506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*